Site of metastasis in metastatic clear cell renal cell carcinoma (mccRCC) and outcome of treatment with sunitinib

被引：2
|
作者：
Beuselinck, B.
Rixe, O.
Oudard, S.
Wolter, P.
Ayllon, J.
Elaidi, R.
Schoffski, P.
Scotte, F.
Zucman-Rossi, J.
Medioni, J.
机构：
[1] Georges Pompidou European Hosp, Dept Med Oncol, Paris, France
[2] Univ Cincinnati, Div Hematol Oncol, Expt Therapeut Program, Cincinnati, OH USA
[3] Catholic Univ Louvain, Leuven Canc Inst, B-3000 Louvain, Belgium
[4] INSERM, Genom Fonct Tumeurs Solides U674, Paris, France
[5] Georges Pompidou European Hosp, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e15065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15065
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
    Loukas F Kontovinis
    Konstantinos T Papazisis
    Panagiota Touplikioti
    Charalambos Andreadis
    Despoina Mouratidou
    Alexandros H Kortsaris
    BMC Cancer, 9
  • [42] Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
    Kontovinis, Loukas F.
    Papazisis, Konstantinos T.
    Touplikioti, Panagiota
    Andreadis, Charalambos
    Mouratidou, Despoina
    Kortsaris, Alexandros H.
    BMC CANCER, 2009, 9
  • [43] Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
    Xu K.Y.
    Wu S.
    Biomarker Research, 3 (1)
  • [44] Association of serum iron and response to immune checkpoint inhibitors (ICIs) in metastatic clear cell renal cell carcinoma (mccRCC)
    Rathi, Nityam
    Stenehjem, David D.
    Agarwal, Neeraj
    Hahn, Andrew W.
    Sirohi, Deepika
    Sharma, Prayushi
    Koh, Mei Yee
    Maughan, Benjamin Louis
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [45] Tumor genomic landscape in younger compared to older patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC).
    Tripathi, Nishita
    Li, Haoran
    Jo, Yeonjung
    Sayegh, Nicolas
    Tandar, Clara
    Nussenzveig, Roberto
    Haaland, Benjamin
    Cheney, Jackson
    Goel, Divyam
    Nordblad, Blake
    Gupta, Sumati
    Maughan, Benjamin L.
    Agarwal, Neeraj
    Swami, Umang
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [46] Real-world comparison of first-line treatments for metastatic clear cell renal cell carcinoma (mccRCC)
    Yazdanpanah, Omid
    Dwabe, Sami
    Harada, Garrett
    Seyedin, Steven
    Mar, Nataliya
    CANCER RESEARCH, 2024, 84 (06)
  • [47] Evolving Landscape of the Treatment of Metastatic Clear Cell Renal Cell Carcinoma
    Ghatalia, Pooja
    Zibelman, Matthew R.
    Geynisman, Daniel M.
    Plimack, Elizabeth R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (10) : 677 - 686
  • [48] Future treatment options in metastatic clear cell renal cell carcinoma
    Simonaggio, Audrey
    Auvray-Kuentz, Marie
    Rochand, Adrien
    Thibault, Constance
    Gervais, Claire
    Oudard, Stephane
    Vano, Yann-Alexandre
    BULLETIN DU CANCER, 2022, 109 (02) : S47 - S58
  • [49] Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology
    Motzer, RJ
    Bacik, J
    Mariani, T
    Russo, P
    Mazumdar, M
    Reuter, V
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (09) : 2376 - 2381
  • [50] Metformin use and outcome of sunitinib treatment in diabetic patients with metastatic renal cell carcinoma.
    Keizman, Daniel
    Ish-Shalom, Maya
    Peer, Avivit
    Gottfried, Maya
    Hammers, Hans J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria J.
    Neiman, Victoria
    Rosenbaum, Eli
    Sarid, David
    Gez, Eli
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Berger, Raanan
    Carducci, Michael Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
12345